Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04796870 · ClinicalTrials.gov registry record · NA

RHBS Brain and Balance Study of Older Adults

A NA study, sponsored by George Mason University.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT04796870: Completed NA study, sponsored by George Mason University.

NCT04796870 is a NA study that has completed, run by George Mason University. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04796870, a NA study, has completed, sponsored by George Mason University.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

Brief Summary: Cognition and balance are known to decline during the aging process. Cognitive performance is essential for functional independence and determines whether an individual can perform instrumental daily living activities (e.g., finances, driving, independent living). Balance is critical for participation in everyday life activities. Impaired balance increases fall risk, and subsequent injury increased caregiver dependency and decreased independence. The purpose of this study is to investigate the outcomes of 24 sessions of online mobility and cognitive training (35 minutes/session, 3x/week, 8-12 weeks) for community-based older adults. The exercise program is progressively challenging and emphasizes balance, cardiovascular conditioning, attention, and working memory. The primary outcomes of interest are cognitive performance and balance changes, with secondary outcomes relating to self-efficacy, resilience, and physical activity.

Primary Outcome

(A) as measured by the Digit Span subset of Wechsler Adult Intelligence Scale- 4th Edition (WAIS-IV); Each correct response is worth 1 point, with a maximum of 14 for each sub-score and for a total score of 24. Higher scores are indicative of better outcome. (B) as measured by Letter-Number Sequencing, each correct response is worth 1 point, with a maximum total score of 21. Higher scores are indicative of better outcome.

Interventions

  • OTHER Online Brain and Balance Training Program

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2021-04-28
Est. Completion 2021-08-02
Phase NA
George Mason University

25 total trials

What the finished NCT04796870 record still lists

NCT04796870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Online Brain and Balance Training Program is the first listed.

NCT04796870 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04796870 about?

NCT04796870 is a clinical study titled "RHBS Brain and Balance Study of Older Adults". Brief Summary: Cognition and balance are known to decline during the aging process. Cognitive performance is essential for functional independence and determines whether an individual can perform instrumental daily living activities (e.g., finances, driving, independent living). Balance is critical...

What is the current status of trial NCT04796870?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2021-04-28. Estimated completion is 2021-08-02.

What interventions are being tested in trial NCT04796870?

The interventions under investigation include: Online Brain and Balance Training Program (OTHER).

Who is sponsoring clinical trial NCT04796870?

This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04796870's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04796870, the US trial registry maintained by the National Library of Medicine. NCT04796870 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.